Teva/Andrx oral contraceptive deal
Executive Summary
Teva acquires exclusive U.S. and Canadian marketing rights to Andrx' generic oral contraceptives awaiting approval, including generic versions of Ortho-McNeil's Ortho-Cyclen, Ortho-Novum 7/7/7 and 1/35, and Ortho Tri-Cyclen. Teva also acquires options for future oral contraceptive products...